Reported Reactions

Devices › Analyzer, chemistry (photometric, discrete), for clinical use

Device brand name · Reaction vessels for chemiluminescent microparticle immunoassays

Architect Reaction Vessel: medical device reports filed with FDA

1,124 reports name it, 2008–2010. Manufacturer given most often on reports: Abbott Laboratories. Product code JJE.

1,124
device reports naming the brand
0% of all MAUDE reports · about 63 a year
0
reports, 12 months to August 2026
0 in the 12 months before
100%
classified as malfunction
95.5% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 1,124 reports that name the brand "Architect Reaction Vessel" (reaction vessels for chemiluminescent microparticle immunoassays), received between October 2008 and June 2010; the manufacturer given most often on reports is Abbott Laboratories. Spellings of one product vary from report to report.

0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (100%); across all analyzer, chemistry (photometric, discrete), for clinical use reports (product code JJE) death is recorded in 0% and malfunction in 95.5%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are device displays incorrect message (89.8%), nonstandard device (20%) and incorrect or inadequate test results (19%). The patient problems coded most often are therapy/non-surgical treatment/delayed/prolonged. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

No report naming Architect Reaction Vessel was received in the five years to August 2026; the latest was received in June 2010.

By year received

04418822008: 820082009: 88220092010: 2342010

Event type and report source

Event type, as classified on the report

Death0%0
Injury0%0
Malfunction100%1,124
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%1,124
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 79,280 reports carrying product code JJE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Device displays incorrect message1,00989.8%2.8%
Nonstandard device22520%0.6%
Incorrect or inadequate test results21419%12%
False positive result494.4%2.6%
High test results393.5%27.1%
No device output211.9%0.1%
Device alarm system111%0.1%
High readingsreadings were too high60.5%0.3%
Unable to obtain readings60.5%0.2%
Incorrect, inadequate or imprecise result or readings40.4%8.9%
Computer software problema software problem30.3%0.4%
False negative result30.3%1.1%
Structural problem30.3%0%
Device inoperablethe device could not be used20.2%0%
Device operates differently than expectedthe device behaved unexpectedly20.2%0.8%
Electrostatic discharge20.2%0%
Output problem20.2%0.5%
Air leak10.1%0%
Mechanical jam10.1%0.1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Therapy/non-surgical treatment/delayed/prolonged10.1%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureArchitect Reaction VesselProduct code JJEAll MAUDE reports
Reports1,12479,28026,136,888
Share of that pool—1.4%0%
Classified as death, per 1,000 reports009
Classified as injury0%1.5%36.2%
Classified as malfunction100%95.5%62.3%
Filed by the manufacturer100%99.6%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code JJE

BrandReportsLatest 12 monthsClassified as death
Access 2 Immunoassay System4,71900%
Unicel Dxi 800 Access Immunoassay System3,13300%
cobas 6000 c501 module2,7321940.1%
COBAS 6000 C (501) Module2,1691290%
UniCel DxC 600i SYNCHRON Access Clinical System2,975130%
Unicel Dxc 800 Synchron System2,23200%
Architect I2000sr Analyzer1,78500.1%
cobas c 503 analytical unit1,4155410%
Alinity Ci-Series Level Sensor Bulk Solution1,33900%
Alinity c Processing Module1,3113020.1%
Cobas 8000 C 702 Module1,28300%
Cobas E 411 Immunoassay Analyzer1,15800.1%
AU5800 Clinical Chemistry Analyzer1,151690%
Dimension Vista 15001,10240%
cobas Integra 400 plus1,103520.1%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about Architect Reaction Vessel reports

How many FDA reports name Architect Reaction Vessel?

1,124 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 0 in the latest 12 months.

What kinds of events are reported?

malfunction (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

device displays incorrect message (89.8%), nonstandard device (20%), incorrect or inadequate test results (19%), false positive result (4.4%) and high test results (3.5%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that Architect Reaction Vessel was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.